Potential Causes of Allodynia Allodynia is associated with several neurological and metabolic conditions, including: Peripheral Neuropathy (due to diabetes, chemotherapy, or autoimmune disorders) Fibromyalgia (central pain sensitisation disorder) Migraine Disorders (involving trigeminal nerve hypersensitivity) Neuroinflammation and Immune Dysregulation (as seen in post-viral syndromes) Medication Side Effects, including possible links to GLP-1 receptor agonists Mechanisms: How GLP-1 Medications May Contribute to Allodynia GLP-1 receptor agonists (e.g., Mounjaro, Wegovy) are widely used for weight loss and glycemic control due to their role in glucose-dependent insulin secretion and appetite suppression
Charlotte Adams*, a 54-year-old woman, gained 30 pounds during menopause
This low energy density means you can eat a visually satisfying portion without consuming a high number of calories
Some people with higher sensitivity to side effects might progress more slowly, while others who handle the medication well might advance slightly faster
The dose is started low and increased slowly so that the body can adjust to side effects
[121] [122] [123] The FDA declared a shortage for Ozempic and Wegovy (but not Rybelsus) starting in August 2022
